Biotech | August 08, 2021
TAKE divests stake in Navitas Life Sciences to HIG
The transaction is expected to close in the Q4FY22
The transaction is expected to close in the Q4FY22
India is dependent upon China and other countries for a lot of Key Starting Materials (KSM) for their bulk drug needs.
This robust growth has come despite the raging pandemic for most part of the quarter
Whole-genome sequencing to identify genetic mutation; epidemiological studies to help assess the distribution and mathematical modelling to forecast spread
The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
MitraClip implants give a new lease of life for frail and elderly patients who cannot go in for conventional open-heart surgery
Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences
Startup receives US $ 5 million in first round of funding
Five seats reserved for Wards of COVID warriors in central MBBS admission
Subscribe To Our Newsletter & Stay Updated
